Shimoda, Fumiko
Naito, Takeo http://orcid.org/0000-0002-6249-2536
Kakuta, Yoichi http://orcid.org/0000-0002-7042-009X
Kawai, Yosuke http://orcid.org/0000-0003-0666-1224
Tokunaga, Katsushi http://orcid.org/0000-0001-5501-0503
Ishibashi-Ueda, Hatsue
Tomita, Tsutomu
Noguchi, Michio
Takahashi, Ayako
Goto, Yu-ichi
Yoshida, Sumiko
Hattori, Kotaro
Matsumura, Ryo
Iida, Aritoshi
Maruoka, Yutaka
Gatanaga, Hiroyuki
Sugiyama, Masaya
Suzuki, Satoshi
Miyo, Kengo
Matsubara, Yoichi
Umezawa, Akihiro
Hata, Kenichiro
Kaname, Tadashi
Ozaki, Kouichi
Tokuda, Haruhiko
Watanabe, Hiroshi
Niida, Shumpei
Noiri, Eisei
Kitajima, Koji
Omae, Yosuke
Miyahara, Reiko
Shimanuki, Hideyuki
Shimoyama, Yusuke
Moroi, Rintaro
Shiga, Hisashi
Nagasaki, Masao http://orcid.org/0000-0002-4292-8785
Kinouchi, Yoshitaka
Masamune, Atsushi
,
Funding for this research was provided by:
AbbVie Inc. | AbbVie Biotherapeutics
Mochida Pharmaceutical Company
Daiichi-Sankyo
Kyowa Hakko Kirin
Janssen Pharmaceuticals
Toshiba International Foundation
AbbVie
Takeda Medical Research Foundation
Article History
Received: 31 March 2023
Revised: 25 June 2023
Accepted: 4 July 2023
First Online: 17 July 2023
Competing interests
: YKakuta received research grants from AbbVie Inc., Mitsubishi Tanabe Pharma Corporation, EA Pharma Co. Ltd., JIMRO Co., Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co. Ltd., Daiichi Sankyo Co. Ltd, Kyowa Kirin Co. Ltd., and Janssen Pharmaceutical K.K. MN received research grants from Toshiba Corporation. AM received research grants from Takeda Pharmaceutical Co. Ltd., AbbVie Inc., Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd., JIMRO Co. Ltd., Mochida Pharmaceutical Co. Ltd., and Zeria Pharmaceutical Co. Ltd.